India's Dr. Reddy's Laboratories Ltd reported a 7.3% rise in its Q2 consolidated net profit.
The company's consolidated net profit climbed to INR3.08 billion, from INR2.87 billion, in the year-ago period. Its consolidated sales surged 21% to INR22.68 billion from INR18.70 billion. However, analysts were expecting a net profit of INR2.93 billion on sales of INR21.40 billion.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in